| Size & multiples | |||
| Market Cap | $21.62B | Enterprise Value | $19.62B |
| P/E (TTM) | — | PEG (trailing) | — |
| P/S | 9.72× | P/FCF | — |
| EV/EBITDA | — | EV/EBIT | — |
| EV/Sales | 8.82× | EV/FCF | — |
| FCF Yield | −7.41% | Buyback Yield | 0.00% |
| Owner Earnings (TTM) | -$3.10B | Owner Earnings Yield | −14.35% |
| Shareholder Yield | — | ||
| Cost of capital & EVAmethodology → | |||
| Beta (5y monthly) | 0.91 | Risk-free (assumed) | 4.00% |
| Equity risk premium (assumed) | 5.00% | Cost of Equity | 8.54% |
| After-tax Cost of Debt | — | WACC | — |
| ROIC | −31.10% | EVA Spread (ROIC−WACC) | — |
| EVA | — | ||
FCF runs above owner earnings — under-maintenance or a working-capital release is flattering current cash.
Flows TTM (last 4 quarters); latest annual for: EPS (Diluted) · EPS TTM -$7.26 · revenue TTM $2.23B · FCF TTM -$1.60B
Output of a disclosed model whose assumptions may be wrong — research information, not investment advice. See the Disclaimer.
Compared against all 1054 Health Care names we cover — one sector-wide pool, so the median skews toward smaller (often unprofitable) companies. Try the Size band for a cap-matched read.
| Metric | This (FY) | Peer median | IQR (25–75) | %ile |
|---|---|---|---|---|
| FCF Yield | -9.6% | -7.9% | -35.6%–1.4% | 47 ↓weak |
| Net Margin | -145.2% | -21.2% | -325.3%–7.2% | 33 ↓weak |
| Operating Margin | -158.1% | -34.5% | -552.0%–8.0% | 36 ↓weak |
| ROE | -28.9% | -36.8% | -92.5%–4.5% | 55 ↑strong |
